Trial intelligence / Profile preview

Bioavailability Study of SPARC001 in Healthy Volunteers

NCT02991222Phase 1Completed

Sponsor
Sun Pharma
Start
Jan 2017
Primary completion
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of hydrocodone bitartrate + acetaminophen in pain (4 arms), sponsored by Sun Pharma. Primary endpoints: Area Under the Curve at 48 hours and Maximum Plasma Concentration at 48 hours. Started Jan 2017; status: completed.

02

Drugs

hydrocodone bitartrate + acetaminophen
03

Conditions

pain

Beyond the preview

Go deeper on NCT02991222.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02991222.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call